Oxygenix Co.,Ltd


	All over the world, Paradigm changes are occurring between the pharmaceutical companies and......			Since founding Oxygenix 2002, I have consistently worked toward constructing a solid business framework for......

With our unique technology that makes it possible to encapsulate proteins and other macromolecular drugs in highly biocompatible liposomes, Oxygenix pursues the following missions:		"Oxygen carrier OXY-0301", our leading drug candidate, is categorized as "Blood derivatives" which are manufactured from donated blood.
Oxygenix was established in order to commercialize its proprietary product based on technologies that can encapsulate proteins and other macromolecular drugs in highly biocompatible liposomes.
Oxygenix's liposome formulation technology imparts new pharmacokinetics and pharmacodynamics to drugs.